Abpro Holdings, Inc. (ABP) IPO - S-1 Filing, Stock & Insider Activity
Abpro Holdings, Inc. IPO - Status & S-1 Filing
- Ticker: ABP
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2025-11-07
- Exchange: NASDAQ
- Expected price range: $20.00–$30.00
- Shares offered: 9,775,017
- SEC CIK: 0001893219 · View the S-1 on SEC EDGAR →
Abpro Holdings, Inc. is pre-IPO, so no insider Form 4 transactions have been filed yet. Once insiders begin reporting trades after the offering, they will appear on this page automatically.
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Abpro Holdings, Inc. (ABP) - no SEC Form 4 insider filings recorded in the last 90 days. 1 Form 8-K material event filing was reported by ABP in the last 90 days. InsiderAlpha tracks every ABP SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Abpro Holdings, Inc. (ABP)
Abpro Holdings, Inc. trades under the ticker ABP. InsiderAlpha tracks 7 primary SEC Form 4 filings from 5 reporting insiders for ABP since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Biological Products, (No Diagnostic Substances) (SIC 2836) |
| SEC CIK | 0001893219 |
90-Day SEC Filing Activity
| Form 8-K filings (90d) | 1 |
|---|---|
| Latest Form 4 filing | 2025-08-04 |
Recent ABP Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jin Wook (Miles) Suk | CEO and Chairman | P - Open-market purchase | 72.0K | $0.28 | $20K | SEC | |
| Jin Wook (Miles) Suk | CEO and Chairman | A - Grant or award | 500.0K | $0.00 | - | SEC | |
| Jin Wook (Miles) Suk | Co-CEO & Chairman | A - Grant or award | 91.9K | $0.00 | - | SEC | |
| Ian Chan | Chief Executive Officer | A - Grant or award | 6.53M | $0.00 | - | SEC | |
| Ian Chan | Chief Executive Officer | A - Grant or award | 1.14M | $0.00 | - | SEC | |
| Ian Chan | Chief Executive Officer | A - Grant or award | 987.4K | $0.00 | - | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Abpro Holdings, Inc. (ABP). Updated in real time as new filings are submitted to the SEC.
Recent ABP Form 8-K Material Events
- - Item 3.01 [SEC]
- - Item 3.01 · Regulatory · negative [SEC]
Abpro Holdings received notification from Nasdaq that its securities will be delisted and trading suspended effective February 23, 2026, due to failure to meet minimum equity standards by the February 16, 2026 deadline. The company plans to appeal but expects its stock to move to
Recent Insider Filings
- - Jin Wook (Miles) Suk (CEO and Chairman)
- - Anthony D. Eisenberg (Director)
- - Jin Wook (Miles) Suk (CEO and Chairman)
- - Soo Young Lee (Director)
- - Ian Chan (Chief Executive Officer)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ABP insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
ABP Insider Trading - FAQ
- What is the latest insider trade for ABP?
- Abpro Holdings, Inc. (ABP) had 0 insider filings in the last 90 days, with the most recent on 2025-08-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying ABP stock?
- 0 insider purchases of ABP were filed in the last 90 days.
- How many insiders are selling ABP stock?
- 0 insider sales of ABP were filed in the last 90 days.
- Where can I see ABP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks ABP Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $AEMD AETHLON MEDICAL INC
- $AHCO AdaptHealth Corp.
- $AIM AIM ImmunoTech Inc.
- $AKTX Akari Therapeutics Plc
- $ALMS ALUMIS INC.
- $ANNX Annexon, Inc.
- $APGE Apogee Therapeutics, Inc.
- $APVO Aptevo Therapeutics Inc.
- $ARTL ARTELO BIOSCIENCES, INC.
- $ARTV Artiva Biotherapeutics, Inc.
Related Companies - Recent Insider Activity
- AMGEN INC (AMGN)
- NEUROCRINE BIOSCIENCES INC (NBIX)
- Twist Bioscience Corp (TWST)
- Kymera Therapeutics, Inc. (KYMR)
- EXELIXIS, INC. (EXEL)
- Moderna, Inc. (MRNA)
- RECURSION PHARMACEUTICALS, INC. (RXRX)
- BioCardia, Inc. (BCDA)
- Maze Therapeutics, Inc. (MAZE)
- MeiraGTx Holdings plc (MGTX)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live ABP dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.